Olink to Science

Olink Signature Q100 makes protein biomarker analysis easier than ever

Can inflammation biomarkers classify different forms of diabetes?

Introducing CORAL, a neurology research consortium using Olink data

Protein biomarkers may predict severe traumatic brain injury mortality

How proteogenomics can improve drug discovery and development

How proteomics using Olink helped advance diabetic kidney disease research

Developing a high-performance biomarker panel for Alzheimer’s disease

Utilizing proteogenomics technology for novel drug target discovery

Dr. Chris Whelan speaks on the topic “Proteomics at Population Scale”

Proteins diagnostic of lung cancer up to 5 years before disease onset

The immune system in the context of chemo and radiation therapy

Older age linked to immunotherapy treatment success

Study identifies key proteins involved in immunotherapy response

Curious about becoming an Olink core lab partner? Watch this!

National University of Singapore becomes our newest core lab partner

Interview with our first European Olink Explore Core lab partner

How to become a successful Olink Explore core lab partner

Introducing the Olink core lab partner series

Olink protein biomarker panel indicates fermented foods fight inflammation

How Olink Explore has been used to understand the pathology of severe COVID-19

The accuracy of Olink Explore 1536 hits the nail on the head

Proteins in the Olink Explore 1536 library

Olink Explore 1536 measures over 1500 proteins

Using Olink PEA technology and RNA-Seq to study disease pathology

How the proteome behaves in healthy individuals

Protein biomarkers are crucial in early detection of cancer

Key proteomics publications from 2020